Requires state contracts for the services of pharmacy benefit managers under health insurance plans for state officers and employees to be procured pursuant to a reverse auction process.
Summary
This bill would require the state, when contracting for pharmacy benefit manager (PBM) services for health insurance benefits for state officers and employees, to use a reverse auction procurement process. A reverse auction is an online bidding process in which qualified PBM bidders compete by lowering their prices over multiple rounds. The bill directs the president to establish the bidding terms, including common definitions, drug classifications, and retail pricing rules, and to do so in consultation with the state comptroller.
The measure also requires PBM bidders to provide complete pharmacy claims data so the state can conduct the auction and manage the contract. It authorizes the state to hire a technology platform vendor and related professional services to run the auction, and allows the cost of that platform to be recovered through a per-prescription fee paid by the PBM. Contract terms could not be changed by the PBM without state approval, and the bill would take effect immediately.
Impact
The bill would amend the civil service law by adding a new section governing procurement of PBM services for state employee health plans. It would shift the state’s contracting process away from ordinary procurement methods and toward a mandatory reverse auction model for PBM contracts, while also creating new authority for the state to collect and use claims data, set standardized bidding terms, and contract for auction technology and support services. The bill primarily affects state procurement officials, PBMs seeking state contracts, and the administration of health insurance benefits for state officers and employees.
Sentiment
Based on the bill text and the absence of recorded committee discussion or votes, the available context suggests a policy-driven, reform-oriented proposal rather than one with documented partisan controversy in the record provided. The bill appears aimed at reducing prescription drug benefit costs through competitive bidding and greater procurement transparency. No formal vote history or transcript comments are available here to indicate broader support or opposition.
Contention
The main points of potential contention are the mandatory reverse auction requirement, the disclosure of complete pharmacy claims data, and the state’s ability to impose standardized contract terms and fee structures. PBMs may object to the data-sharing requirement, limits on contract modification, and the competitive pressure of an auction process, while supporters are likely to view those same provisions as necessary to increase competition and lower costs for the state and its employees. Another possible issue is the use of a technology vendor and per-prescription fee to fund the auction platform, which could raise questions about implementation and administrative complexity.